Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...

Shingrix's manufacturer, GlaxoSmithKline, didn't anticipate it would be so popular when it first hit the market. In the first six months of 2018 alone, more doses of Shingrix were administered in ...

Shingrix, the new shingles vaccine, is over 90 percent effective in preventing the painful viral infection Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL ...

If you’re 50 or older, Judith Strull's story might sound familiar. Told by her doctor last month to get the new shingles vaccine, Shingrix, she went to her local CVS in Newton, Mass., expecting ...

Shingles Vaccine Shortage: What You Must Know Because of high demand, Shingrix, the two-dose vaccine approved in 2017 to prevent shingles and its blistery skin rash, continues to be in short sup ...

Shingrix is contraindicated for immunocompromised adults with a history of severe allergies, anaphylaxis, or those with prior vaccine-related adverse reactions, according to the vaccine's label.

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...